Loading clinical trials...
Loading clinical trials...
The purpose of the study is to validate the ItchRO instrument (a clinical outcome assessment measure of itching) prior to the analysis of longitudinal treatment effect data being generated in ongoing ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mirum Pharmaceuticals, Inc.
NCT05035030 · Alagille Syndrome
NCT07185919 · Progressive Familial Intrahepatic Cholestasis
NCT06850038 · Alagille Syndrome
NCT07191704 · PFIC - Progressive Familial Intrahepatic Cholestasis
NCT07293897 · Alagille Syndrome (ALGS), Progressive Familial Intrahepatic Cholestasis (PFIC)
Phoenix Childrens Hospital
Phoenix, Arizona
Children's Hospital Colorado
Aurora, Colorado
St. Louis Children's Hospital
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions